Limited information is available regarding epigenomic events mediating initiation and progression of tobacco-induced lung cancers. In this study, we established an in vitro system to examine epigenomic effects of cigarette smoke in respiratory epithelia. Normal human small airway epithelial cells and cdk-4/hTERT-immortalized human bronchial epithelial cells (HBEC) were cultured in normal media with or without cigarette smoke condensate (CSC) for up to 9 months under potentially relevant exposure conditions. Western blot analysis showed that CSC mediated dose-and timedependent diminution of H4K16Ac and H4K20Me3, while increasing relative levels of H3K27Me3; these histone alterations coincided with decreased DNA methyltransferase 1 (DNMT1) and increased DNMT3b expression. Pyrosequencing and quantitative RT-PCR experiments revealed time-dependent hypomethylation of D4Z4, NBL2, and LINE-1 repetitive DNA sequences; up-regulation of H19, IGF2, MAGE-A1, and MAGE-A3; activation of Wnt signaling; and hypermethylation of tumor suppressor genes such as RASSF1A and RAR-b, which are frequently silenced in human lung cancers. Array-based DNA methylation profiling identified additional novel DNA methylation targets in soft-agar clones derived from CSC-exposed HBEC; a CSC gene expression signature was also identified in these cells. Progressive genomic hypomethylation and locoregional DNA hypermethylation induced by CSC coincided with a dramatic increase in soft-agar clonogenicity. Collectively, these data indicate that cigarette smoke induces 'cancer-associated' epigenomic alterations in cultured respiratory epithelia. This in vitro model may prove useful for delineating early epigenetic mechanisms regulating gene expression during pulmonary carcinogenesis.
Limited information is available regarding epigenomic events mediating initiation and progression of tobacco-induced lung cancers. In this study, we established an in vitro system to examine epigenomic effects of cigarette smoke in respiratory epithelia. Normal human small airway epithelial cells and cdk-4/hTERT-immortalized human bronchial epithelial cells (HBEC) were cultured in normal media with or without cigarette smoke condensate (CSC) for up to 9 months under potentially relevant exposure conditions. Western blot analysis showed that CSC mediated dose-and timedependent diminution of H4K16Ac and H4K20Me3, while increasing relative levels of H3K27Me3; these histone alterations coincided with decreased DNA methyltransferase 1 (DNMT1) and increased DNMT3b expression. Pyrosequencing and quantitative RT-PCR experiments revealed time-dependent hypomethylation of D4Z4, NBL2, and LINE-1 repetitive DNA sequences; up-regulation of H19, IGF2, MAGE-A1, and MAGE-A3; activation of Wnt signaling; and hypermethylation of tumor suppressor genes such as RASSF1A and RAR-b, which are frequently silenced in human lung cancers. Array-based DNA methylation profiling identified additional novel DNA methylation targets in soft-agar clones derived from CSC-exposed HBEC; a CSC gene expression signature was also identified in these cells. Progressive genomic hypomethylation and locoregional DNA hypermethylation induced by CSC coincided with a dramatic increase in soft-agar clonogenicity. Collectively, these data indicate that cigarette smoke induces 'cancer-associated' epigenomic alterations in cultured respiratory epithelia. This in vitro model may prove
Introduction
Mounting evidence implicates aberrant expression/ activity of epigenetic regulators of gene expression in the initiation and progression of lung cancers, the majority of which are directly attributable to cigarette smoking (Lee et al., 2005; D'Alessio and Szyf, 2006; Lin et al., 2007; Schrump et al., 2007) . For example, increased DNA methyltransferase (DNMT) expression coincides with progression to malignancy in murine pulmonary adenomas induced by tobacco carcinogens (Belinsky et al., 1996) . Over-expression of DNMT1 and DNMT3b, as well as methyl-binding domain 2, correlates with hypermethylation of tumor suppressor genes in tobacco-induced lung cancers, and diminished survival of patients with these neoplasms (Kim et al., 2006; Lin et al., 2007; Xing et al., 2008) . Aberrant activities of histone lysine methyl transferases and histone deacetylases enhance oncogenic transformation of bronchial epithelial cells (Watanabe et al., 2008) , and induce global alterations in the histone code, which correlate with advanced stage of disease and poor prognosis in lung cancer patients (Barlesi et al., 2007; Van Den et al., 2008; Seligson et al., 2009) . Over-expression of polycomb proteins such as Bmi 1 and Ezh2 facilitates epigenetic silencing of tumor suppressor genes, and enhances stem cell signaling in lung cancer cells (Dovey et al., 2008; Vrzalikova et al., 2008; Hussain et al., 2009; McCabe et al., 2009) .
Epigenetic alterations during malignant transformation seem analogous to those regulating gene expression during gametogenesis and stem cell development (Simpson et al., 2005; Mathews et al., 2009) . For example, tumor suppressor genes such as p16 and p19/ARF, which mediate replicative senescence and apoptosis in response to oncogene signaling (Agherbi et al., 2009) , are frequently observed to be silenced in cancer cells exhibiting coordinate de-repression of germ-line restricted genes such as NY-ESO-1 and MAGE family members, several of which physically interact and suppress p53-mediated apoptosis (Cho et al., 2006; Monte et al., 2006; Yang et al., 2007) . These observations suggest that epigenetic perturbations in lung cancer cells are not merely manifestations of random stochastic events, but instead reflect strong selective pressure to reactivate/maintain stem cell gene expression during multistage pulmonary carcinogenesis.
Despite the unequivocal association between cigarette smoking and lung cancer, the epigenetic mechanisms by which tobacco smoke initiates and promotes pulmonary carcinogenesis have not been fully delineated. In particular, epigenetic events associated with initiation of tobacco-induced lung cancers have not as yet been elucidated. This study was undertaken to characterize epigenomic alterations in cultured human respiratory epithelial cells mediated by cigarette smoke.
Results

Growth inhibitory effects of cigarette smoke condensate in cultured cells
Preliminary experiments were initiated to examine the effects of cigarette smoke condensate (CSC) in cultured respiratory epithelia and lung cancer cells to define appropriate exposure conditions for subsequent studies. As shown in Figure 1a , CSC mediated dose-dependent growth inhibition, which coincided with morphologic changes in cultured respiratory epithelia; after CSC exposure, cdk-4/h-Tert immortalized human bronchial epithelial cells (HBEC), and to a lesser extent normal human small airway epithelial cells (SAEC) became less polygonal and appeared more elongated and rectangular in shape. Interestingly, under these exposure conditions, the effects of CSC were less apparent in fully transformed A549 lung cancer cells.
'Cancer-associated' histone alterations mediated by CSC Malignant transformation is associated with global loss of monoacetylated H4K16 as well as decreased H4K20me3 levels (Fraga et al., 2005; Van Den et al., 2008) . As such, western blot experiments were performed to ascertain whether CSC exposure could induce these histone changes in respiratory epithelial cells. Briefly, SAEC and HBEC were cultured in normal media with or without CSC at various concentrations and exposure durations. As shown in Figure 1b (upper panel) , within 24 h of exposure, CSC mediated a dosedependent decrease in H4K16Ac levels, without appreciably changing total H4 expression in HBEC. A similar phenomenon was observed after 24 or 48 h CSC exposure. Densitometry analysis revealed no appreciable change in H4K20Me3 levels under these exposure conditions. Additional analysis using indirect immunofluorescence techniques (Figure 1b , lower panel) confirmed results of aforementioned western blot experiments. Short-term CSC exposure mediated dosedependent decreases in H4K16Ac levels without appearing to alter H4K20Me3 levels in short-term normal human bronchial epithelial (NHBE) cells as well as SAEC (Figure 1c) , suggesting that the acute effects of CSC exposure on the histone code were not unique to immortalized HBEC.
Additional experiments were performed to examine the effects of prolonged CSC exposures in immortalized HBEC. Representative results of this analysis are depicted in Figure 1d . Relatively low concentrations of CSC (1%) mediated time-dependent decreases in H4K16Ac, as well as H4K20me3 levels; reduced levels of H4K16Ac-but not H4K20Me3-were observed in HBEC 5 days after initiation of CSC exposure. Decreased H4K20Me3 levels were evident in HBEC 1 month after initiation of CSC exposure. More prolonged exposure to 1% CSC virtually abolished H4K16Ac, and dramatically reduced H4K20Me3 levels without significantly diminishing total H4 levels in HBEC; these histone alterations coincided with a 2.6-fold relative increase in H3K27Me3, an 80% reduction in DNMT1, as well as B2-3-fold increase in EZH2 and DNMT3b levels, respectively.
DNA methylation changes mediated by CSC
Additional experiments were performed to ascertain whether CSC exposure altered global DNA methylation status in HBEC. Initial pyrosequencing experiments focused on NBL2-seq3 and D4Z4 DNA repeats, as well as LINE-1 elements, as these have been shown to be demethylated in cancer cells exhibiting decreased levels of H4K16Ac and H4K20Me3 (Fraga et al., 2005) . Preliminary analysis showed modest demethylation of these sequences in untreated immortalized HBEC relative to primary cultures of SAEC or NHBE cells, although not to the extent observed in A549 lung cancer cells (Figure 2a) . Subsequent experiments revealed a dose-dependent demethylation of NBL2 and D4Z4 subtelomeric DNA repeats, and to a lesser extent, LINE-1 elements in HBEC after 5-month continuous CSC exposure (Figure 2b ).
Quantitative RT-PCR experiments were performed to ascertain whether hypomethylation of the aforementioned repetitive DNA sequences coincided with activation of imprinted loci, as well as cancer-testis-X chromosome (CT-X) genes that are frequently derepressed in primary lung cancers through epigenetic mechanisms. As shown in Figure 2c (left panel), CSC mediated dose-dependent up-regulation of IGF2 and H19 imprinted loci, as well as several CT-X genes, including MAGE-A1 and MAGE-A3. Interestingly, NY-ESO-1 (cancer-testis antigen 1), a CT-X gene frequently de-repressed in lung cancer cells , did not seem to be activated in HBEC by CSC under these exposure conditions.
Additional experiments were performed to determine whether enhanced expression of IGF2 and H19 was due to mono-allelic up-regulation of these loci, or loss of imprinting. Genomic sequencing (Figure 2c , right panel) revealed polymorphisms that could distinguish maternal and paternal IGF2 and H19 alleles in HBEC; additional pyrosequencing experiments indicated that only the paternal IGF2 and the maternal H19 alleles were expressed in untreated as well as CSC-exposed HBEC. These data suggested that increased IGF2 and H19 expression in HBEC after 5-month CSC exposure was due to mono-allelic up-regulation of the normally expressed alleles, rather than loss of imprinting. These findings are consistent with the data reported by Kaplan et al. (2003) after exposure of NHBE to cigarette smoke.
Epigenetics of tobacco smoke exposure F Liu et al Additional qRT-PCR and pyrosequencing experiments were performed to examine whether CSC exposures sufficient to induce global DNA demethylation also mediated repression of tumor suppressor genes typically silenced in human lung cancers by DNA hypermethylation mechanisms. As shown in Figure 2d , CSC exposure did not appear to alter expression or methylation status of p16, E-cadherin, DAP kinase, or MGMT. However, CSC mediated dose-dependent diminution of RASSF1A as well as Dickkopf-1 (Dkk-1) expression; repression of RASSF1A, but not Dkk-1, coincided with promoter hypermethylation. The results pertaining to Dkk-1 repression in HBEC after CSC exposure were consistent with recent data showing that cigarette smoke induces polycomb-mediated repression of Dkk-1 in lung cancer cells (Hussain et al., 2009) . Interestingly, CSC mediated dose-dependent hypermethylation without appreciably diminishing expression Densitometry analysis revealed time-dependent decreases in H4K16 acetylation and H4K20 trimethylation without appreciable alterations in total histone H4 levels. These alterations coincided with a relative increase in H3K27 trimethylation as well as a modest increase in EZH2, the polycomb protein mediating this repressive mark. These phenomena, which were evident after 5-month CSC exposure, coincided with a decrease in DNMT1:DNMT3b protein ratios.
Epigenetics of tobacco smoke exposure F Liu et al of RAR-b, which is frequently silenced through epigenetic mechanisms in tobacco-associated lung cancers (Toyooka et al., 2003 (Toyooka et al., , 2006 .
Activation of Wnt signaling by CSC
As CSC exposure silenced Dkk-1, additional experiments were performed using focused qRT-PCR arrays Right panel: Pyrosequencing analysis of genomic DNA and cDNA pertaining to IGF2 and H19 in control HBEC as well as HBEC exposed to CSC for 5 months. Genotyping revealed polymorphisms that could distinguish between maternal and paternal alleles of IGF2 and H19. After prolonged CSC exposure, only the maternally imprinted IGF2 and the paternally imprinted H19 loci were expressed. These results suggest that enhanced expression of these loci was attributable to mono-allelic up-regulation rather than loss of imprinting. (d) qRT-PCR with representative RT-PCR, and pyrosequencing analyses of tumor suppressor gene loci in HBEC after prolonged CSC exposure (upper and lower panels, respectively). A progressive, dose-dependent increase in promoter methylation was observed in RASSF1A and RAR-b promoter regions. No apparent hypermethylation was observed in several tumor suppressor genes such as p16, E-cadherin, DAP kinase, and MGMT, which are frequently silenced in tobacco-associated lung cancers by epigenetic mechanisms. DAP kinase expression in untreated and CSC-exposed HBEC was exceedingly low. Dkk-1 was not methylated, but was repressed, a phenomenon possibly attributable to polycomb repressor complexes (Hussain et al., 2009) . Diminution of RASSF1A expression coincided with hypermethylation of the RASSF1A promoter. Hypermethylation of RAR-b seemed insufficient to silence this gene under exposure conditions used for these experiments.
Epigenetics of tobacco smoke exposure and D4Z4, and hypermethylation of RASSF1A and RAR-b, but not p16, DAPK, E-cadherin, or CDH13 ( Figure 4c ). Five soft-agar clones arising spontaneously from control HBEC and B30 clones derived from HBEC exposed to CSC for 9 months were expanded for further analysis. Pyrosequencing experiments indicated that methylation profiles in spontaneous and CSCderived clones reflected those observed in untreated and CSC-exposed cell populations, respectively (Figure 4d ). The fact that consistent methylation profiles were observed in CSC-derived relative to control clones strongly suggests that enhanced clonogenic potential of CSC-treated HBEC was a manifestation of selection pressure mediated by CSC on the HBEC epigenome, A progressive time-dependent increase in RASSF1A and RARb promoter methylation was observed without an apparent increase in methylation of p16, DAPK, E-cadherin, or CDH13. Increased clonogenic potential also coincided with a time-dependent decrease in methylation status within DNA repeats, particularly NBL2 and D4Z4. (d) Pyrosequencing analysis of DNA methylation in soft-agar clones emerging spontaneously from untreated HBEC and representative soft-agar clones derived from HBEC exposed to CSC for 9 months. The CSC-exposed clones showed markedly diminished methylation status within NBL2 and D4Z4, findings which were consistent with results observed in bulk cultures. Once again, there was no change in methylation status within p16, DAPK, E-cadherin, H-cadherin, or MGMT. However, clones derived from CSC-exposed HBEC exhibited markedly increased methylation status of RASSF1A and RARb. These data suggest that CSC induced alterations, which contributed to enhanced clonogenicity rather than selecting for outgrowth of cells exhibiting aberrant methylation profiles in bulk untreated HBEC.
Epigenetics of tobacco smoke exposure F Liu et al rather than outgrowth of cells exhibiting aberrant DNA methylation already present in untreated pooled HBEC. Despite the dramatic increase in soft-agar clonogenicity of CSC-treated HBEC, no tumors were observed in 100 nude or NOD.SCID\IL-2Rg null mice inoculated in contralateral flanks with control HBEC and one of the six CSC-derived soft-agar clones (data not shown).
Array analysis of DNA methylation and gene expression mediated by CSC Illumina array techniques were used to more comprehensively examine DNA methylation and gene expression profiles in HBEC exposed to CSC. Briefly, sodium bisulfite-modified DNA samples derived from untreated and CSC-exposed HBEC, as well as soft-agar clones derived from control and CSC-exposed HBEC, were analyzed using the Illumina Infinium methylation assays that measure DNA methylation at over 27 000 CpG loci distributed among 414K genes. Also profiled were bisulfite-modified DNAs derived from several established lung cancer lines. Partial results of this analysis are depicted in Figure 5 . Short-term (5 days) CSC exposure had negligible effects in SAEC and HBECs (data not shown). However, using an absolute value DiffScore 425, which corresponded to Po0.05, 48 targets appeared to become demethylated, whereas 56 targets exhibited increased methylation in HBEC after 9-month CSC exposure ( Figure 5a ; Table 1 ). The Illumina methylation assays were non-informative for global methylation, but rather provided locus-specific methylation measurements; however, pyrosequencing data were consistent with global genomic demethylation occurring in the context of locoregional hypermethylation. Overall, methylation profiles in spontaneous softagar clones derived from untreated HBEC were virtually identical to those observed in pooled, control HBEC. Furthermore, methylation changes observed in soft-agar clones from CSC-exposed HBEC expanded under CSC exposure were remarkably similar to those observed in the same clones expanded in the absence of CSC. These findings strongly suggest that DNA methylation changes induced by prolonged CSC treatment were quite stable and heritable. Several CpG targets, including RASSF1A, LOX, and CALCA, that exhibited DNA hypermethylation in HBEC after CSC exposure were also noted to be methylated in cultured lung cancer lines; in contrast, other targets such as MEG-3, HOXA9, TFF-2, and GNAS that were methylated in several cultured as well as primary lung cancers did not appear to be methylated in HBEC after CSC exposure (data not shown). These results suggest that either more prolonged CSC exposures, or cigarette smoke components not present in the condensates are necessary to further shift DNA methylation profiles in HBEC toward those typically observed in cultured non-small cell lung cancers.
A variety of CpG targets observed to become relatively hypo-or hypermethylated in HBEC by CSC exposure have not been typically associated with lung cancer development. For example, heat shock proteinbinding protein 1 (HSPB1) and phospholipase D-5 seemed to become hypermethylated in HBEC after prolonged CSC exposure ( Figure 5a ; Table 1 ). Quantitative RT-PCR and pyrosequencing experiments revealed that CSC exposure diminished expression of HSPB1 coincident with increased methylation of the HSPB1 promoter (Figures 5b and c) . This phenomenon was not observed for phospholipase D-5 (data not shown). Subsequent chromatin immunoprecipitation (ChIP) experiments revealed that CSC exposure diminished H3K9Ac, while increasing H3K27Me3 levels within the HSPB1 promoter ( Figure 5d) ; no appreciable change in H4K16Ac level within the HSPB1 promoter was observed in these ChIP experiments (data not shown). Analysis of a panel of cultured respiratory epithelial lines revealed that HSPB1 levels in immortalized bronchial epithelial cells and numerous lung cancer lines appeared lower than those detected in SAEC. Interestingly, HSPB1 expression in spontaneous clones appeared lower than those observed in untreated controls (but higher than in CSC-treated cells/clones). Collectively, these data raise the possibility that HSPB1 Figure 5 (a) Illumina array analysis of DNA methylation in control bulk HBEC, control spontaneous soft-agar clones, and soft-agar clones derived from HBEC exposed to CSC for 9 months. Treatment groups were as follows-1: control untreated HBEC; 2: control spontaneous soft-agar clones; 3: CSC-derived soft-agar clones expanded in the absence of CSC; 4: CSC-derived soft-agar clones expanded in the presence of CSC; 5: pooled HBEC exposed to CSC for 9 months. Each lane pertains to an individual clone or pooled sample. Spontaneous clones exhibited methylation profiles remarkably similar to those observed in untreated HBEC cells. In contrast, CSC-exposed clones showed considerable alterations in methylation status across numerous gene loci. Additional short-term CSC exposure did not seem to further alter methylation profiles in CSC-derived soft-agar colonies. Heat map represents a differential score 425 for genes hypo-or hypermethylated by CSC treatment. These data are summarized in Table 1 H82  H123  H128  H345  H520  H526  H889  H1618  H1688  H2028  H2721  H841  HBEC  BEAS   fold/SAEC   GAD1  C2orf10  FAM105A  ZNF467  HOXA9  MOBKL2A  FLJ31196  NOS3  MEG3  GPR97  BCNP1  RLN1  GNAS  RAB11FIP2  ARR3  MC2R  MSR1  ZNF264  XKRX  NMBR  ADORA2A  CCRL2  UNQ6411  CCND1  DNM1L  DGCR2  VHL  ITM2A  IL1RAPL2  BAGE  CHRFAM7A  UROS  PPP3R2  FXN  ABCC6  PRRG2  SUMF1  SLC26A3  VHL  DNTTIP2  FAM71C  TFF2  TBC1D21  MYR8  GHRH  FLJ38451  HEM1  CCND1  CFLAR  ATP10A  RASA4  VAV3  NELL2  TGFBR1  UBE2G1  GATA4  PRG-3  TUBB2B  ST3GAL4  ADAMTS17  NKX2-2  CALCA  IGF2AS  STON1  FLJ13391  DRD1  DRD5  PRRX1  MOXD1  CPT1A  PCSK6   PTN  KIF1A  PTGDR  C1orf65  MEGF11  CLSTN2   GRID2  KCNJ8  C1QTNF1  NMUR1  HSPB1  IRXL1  ABHD7   SOCS1  RARB  TSSK3  CILP2  WNT3A  INA  CCDC37  PLD5  KCNJ8  PNMA2  DOCK2  RASSF1  C1QTNF1 
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Epigenetics of tobacco smoke exposure F Liu et al mediated down-regulation of HSPB1 has not been firmly established.
Additional correlative Illumina array experiments were performed to examine gene expression profiles mediated by CSC, using RNA harvested from cells providing DNA for the aforementioned DNA methylation arrays. The results of this analysis are depicted in Figure 6 . Gene expression profiles in control spontaneous soft-agar clones were remarkably similar to those in pooled untreated HBEC. In contrast, gene expression profiles in six randomly selected soft-agar clones derived from HBEC exposed to CSC for 9 months (Figure 4d) , and expanded in the absence of CSC were considerably different than those observed in controls, and seemed to Epigenetics of tobacco smoke exposure F Liu et al represent stable sequelae of epigenetic (and presumably genetic) alterations induced by CSC. Profiles in CSCderived soft-agar clones expanded in the absence of smoke were markedly different from those detected in the same clones after 6-day CSC exposure (Figure 6a , lanes 3 and 4). Using criteria of Xtwofold relative to controls and Po0.05, 85 genes were up-regulated, whereas 109 genes were repressed in CSC-derived softagar clones expanded in the absence of CSC. Using similar criteria, 230 genes were induced, whereas 295 were repressed in these CSC-derived soft-agar clones expanded under CSC exposure. Interestingly, 44% of differentially modulated genes were up-regulated, whereas 56% were repressed in CSC-derived soft-agar clones expanded under either treatment condition. Ingenuity pathway analysis revealed that networks involving antigen presentation/ immune response, organ development, tissue morphology/cancer, DNA replication/repair, and inflammation were preferentially modulated in CSC-derived soft-agar clones expanded in the absence of CSC. In contrast, networks preferentially modulated in these soft-agar clones expanded in the presence of CSC included cellular movement, small molecule biochemistry/gene expression, and genetic disorders (data available on request). Several pathways preferentially modulated in these clones are depicted in Figure 6b . Table 2 contains a list of the top 100 genes differentially modulated in CSC-derived soft-agar clones expanded in the absence or presence of CSC relative to control (spontaneous) soft-agar clones. Fifteen of the top 50 genes (30%) activated in CSC-derived clones expanded in the absence of CSC were among the top 50 genes activated in these clones after additional CSC exposure. In contrast, 23 of the 50 most repressed genes (46%) in CSC-derived soft-agar clones expanded in the absence of CSC were among the top 50 most repressed genes in these clones after CSC exposure. Although some exceptions were noted, the magnitude of repression of genes simultaneously down-regulated in CSC-derived soft-agar clones expanded in the absence or presence of CSC (that is TXNIP, DUSP23, VIM) was relatively comparable. In contrast, CSC seemed to enhance the magnitude of activation of genes such as SPANXB1, KLK6, and KYNU that were up-regulated in CSC-derived clones expanded under both treatment conditions. Overall, these data raise the possibility that repression was more stable than activation of gene expression in HBEC after prolonged CSC exposure. Epigenetics of tobacco smoke exposure F Liu et al 2008; Wu et al., 2009) . Although informative, these studies are inconclusive as the effects of single tobacco components are unlikely to represent those mediated by the complex mixture of organic as well as inorganic carcinogens detected in tobacco smoke (Smith et al., 2003; Shin et al., 2009) . Indeed, genetic responses of cultured respiratory epithelia to tobacco carcinogens vary considerably depending on which components from air/liquid interphase such as nicotine, cadmium, and NNK, or vapor phase such as formaldehyde or ethyl carbamate are used for the exposures (Sexton et al., 2008) . Additional studies using CSCs have produced variable results depending on the type of condensates and treatment conditions used for the experiments, including supplementation of culture media with S9 microsomal fractions to enhance activation of tobacco carcinogens in respiratory epithelial cells (Jorgensen et al., 2004; Fields et al., 2005) . In this study, we focused our efforts on characterizing the epigenomic effects of CSC in SAEC and HBEC, acknowledging that neither was perfect for this analysis. For example, SAEC, which theoretically contain true target cells of tobacco carcinogens, spontaneously senesce after several passages in culture. On the other hand, immortalization may have subtly perturbed chromatin structure, and altered susceptibility of HBEC to tobacco carcinogens.
Despite these potential limitations, our experiments yielded several interesting and potentially relevant findings. For example, CSC exposure dramatically decreased acetylation of H4K16, and subsequently diminished H4K20 trimethylation in cultured respiratory epithelia. These histone modifications have been observed in several malignancies, including lung cancers (Fraga et al., 2005; Van Den et al., 2008) . Given the highly dynamic nature of histone modifications in response to environmental stimuli including tobacco carcinogens (Hussain et al., 2009; Jensen et al., 2009; Zhou et al., 2009) , it is not surprising that modulation of the histone code seemed to precede aberrant DNA methylation typically observed in lung cancers (Toyooka et al., 2003 (Toyooka et al., , 2006 . Moreover, our data suggest that demethylation of repetitive DNA sequences, monoallelic up-regulation of H19 and IGF2, as well as de-repression of several CT-X genes such as MAGE-A1, MAGE-A3, and SPANXB1, precedes DNA methylation-mediated silencing of tumor suppressor genes, such as p16, MGMT, DAPK, E-cadherin, and cdh13 during tobacco-induced pulmonary carcinogenesis. These findings suggest that global DNA demethylation is an early event during-not a consequence of-malignant transformation. Interestingly, progressive global DNA demethylation with consistent hypermethylation of RASSF1A-a tumor suppressor frequently silenced by epigenetic mechanisms in tobacco-induced lung cancers (Richter et al., 2009) , and activation of Wnt signaling coincided with increased clonogenicity of HBEC. The fact that CSC-exposed HBEC were not tumorigenic in murine hosts suggests that additional epigenetic alterations that silence other tumor suppressors or activate stem cell genes such as Oct4, SOX, and NANOG-a phenomenon not observed in our present studies (data not shown), may be necessary to fully transform these cells.
Despite the fact that DNA methylation and gene expression profiling could readily discriminate between control and CSC-exposed HBEC, little correlation was observed between DNA methylation and gene expression profiles for any given treatment condition. These discrepancies may be attributable to the fact that many of the CpG targets on the methylation arrays are not within promoter regions; furthermore, modulation of gene expression by CSC may occur through mechanisms independent of DNA methylation (Kang et al., 2007; Hussain et al., 2009) . Overall, these findings are consistent with data indicating that hypermethylation of CpG islands in cancer cells frequently involves genes, which typically do not mediate proliferation or tumorigenicity (Keshet et al., 2006) , as well as a recent report showing no correlation between DNA methylation and gene expression profiles in follicular lymphomas (Killian et al., 2009 ).
The results of our studies vary considerably from those reported by Damiani et al. (2008) , who observed that the tobacco carcinogens methyl-nitrosourea and benzo (a) pyrene-diolepoxide increased DNMT1 levels, and induced hypermethylation of E-cadherin, CDH13, proto-cadherin 10, GATA5, and PAX5 in HBEC; these epigenetic alterations coincided with enhanced soft-agar clonogenicity, but not tumorigenicity in nude mice. Notably, in Damiani's model as well as ours, p16 was neither silenced nor hypermethylated by carcinogen exposure, despite the fact that inactivation of this tumor suppressor gene is believed to be a frequent, early event during tobacco-induced pulmonary carcinogenesis (Toyooka et al., 2006) . In our experiments, CSC exposure seemed insufficient to inactivate E-cadherin and CDH13, yet mediated progressive DNA hypermethylation of RASSF1A and RAR-b, which are known to be targets of aberrant DNA methylation in human lung cancers (Licchesi et al., 2008; Seng et al., 2008) ; these alterations seemed to coincide with a markedly increased DNMT3b/ DNMT1 protein ratio. Discrepancies regarding results reported by Damiani et al. (2008) and our current findings may be attributable (at least in part) to exposure conditions including the use of purified, activated carcinogens, serum supplementation and avoidance of oxidative stress by Damiani et al. (2008) rather than CSC, serum-free media and oxidative stress used for our experiments.
From a clinical biomarker discovery perspective, the predictive value of the model described in this manuscript seems to be relatively low regarding identification of differentially methylated genetic targets during cigarette smoke-induced pulmonary carcinogenesis. Conceivably, additional CSC exposures will induce epigenetic alterations in HBEC more typically observed in lung cancer cells; these experiments are ongoing in our laboratory. Despite potential limitations, this model may enable investigation of a variety of epigenetic mechanisms contributing to tobacco-induced lung cancers, and evaluation of novel agents for the treatment and prevention of these neoplasms.
Materials and methods
Cell culture
All lung cancer cell lines were obtained from American Type Culture Collection (Manassas, VA, USA) and maintained in RPMI media supplemented with 10% FBS and 10 mM glultamic acid. SAEC and NHBE were obtained from Lonza, Inc. (Frederick, MD, USA), and cultured in appropriate media (SAGM and BEBM, respectively) according to vendor instructions. HBEC were generously provided by John D Minna (U-T Southwestern, Dallas, TX, USA), and cultured in complete Keratinocyte-SFM media (Invitrogen, Carlsbad, CA, USA) supplemented with 5 mg/l epidermal growth factor and 50 mg/l bovine pituitary extract. Cell proliferation was assessed by MTT techniques.
Generation of CSCs and cell line exposure CSCs were generated from Kentucky 2R4F research cigarettes (University of Kentucky, Tobacco and Health Research Institute, Lexington, KY, USA) using a Borgwaldt-LM1 smoking machine (Richmond, VA, USA) and standard Federal Trade Commission smoking conditions (35 ml puff volume, 2.0 s duration, and 1 puff/min, 9 puffs/cigarette). The smoke condensates were trapped on Cambridge glass fiber filters, weighed, and dissolved in K-SFM, RPMI, SAGM, and BEBM media, respectively, at a concentration of 1 mg/ml, which was defined as 10% CSC (Narayan et al., 2004) .
CSC treatments NHBE, SAEC, HBEC, and A549 cells were plated in six-well plates or 10 cm 2 culture dishes in appropriate normal media with or without CSC in the absence of microsomal supplementation. Media and CSC were changed daily. At appropriate times, cells were harvested, and processed for further analysis.
Genomic DNA isolation, bisulfite conversion, and pyrosequencing Genomic DNA was isolated from cells using the DNeasy Blood and Tissue kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol. A total of 0.5 mg of DNA was used for bisulfite conversion by using EpiTect Bisulfite kit (Qiagen). Bisulfite-modified DNA was dissolved in 30 ml H 2 O, and 2 ml of DNA template was used for pyrosequencing PCR amplification. Dispensation order pyrosequencing reactions and data analysis were performed using the Pyromark MD pyrosequencer with software provided by Biotage (Charlottesville, VA, USA). p16, MGMT, and Line-1 pyrosequencing primers were obtained from Biotage; additional pyrosequencing primer sequences are included in Supplementary Table 1. RNA extraction and quantitative real-time RT-PCR Submitted as Supplementary Information.
Western blot
Immunoblotting of non-histone proteins was performed as described (Hussain et al., 2009) ; western blot analysis of histones was performed according to Millipore protocols, with minor modifications (detailed methods submitted as Supplementary Information). Antibodies used for immunoblotting included H4K16Ac (Abcam ab1762 Cambridge, MA, USA), H4K20Me3 (Upstate 07-463 Billerica, MA, USA), H3K27Me3 (Upstate 07-449), total H3 (Upstate 05-499), and total H4 (Abcam ab10158), DNMT1 (Abcam ab16632-100), DNMT3b (Cell Signal, 2161s, Boston, MA, USA), and EZH2 (BD, 612667, Woburn, MA, USA). Western blot signals were detected with the appropriate secondary-HRP-conjugated antibodies and ECL reagent (Amersham, Pittsburgh, PA, USA), followed by densitometric analysis.
RT-PCR superarrays
Wnt signaling RT-PCR superarrays (PAH-043A) and Human Stress and Toxicity Pathway Finder (PAH-003A) were obtained from SABiosciences (Frederick, MD, USA). Full details of these methods are submitted as Supplementary Information.
Chromatin immunoprecipitation
ChIP was performed using reagents and protocols contained in the Millipore 17-295 ChIP kit (Billeria, MA, USA), and ChIPgrade antibodies recognizing H3K9Ac (ab4441-50; Abcam) or H3K27me3 (07-449; Millipore, Billerica, MA, USA). Full methods and primer sequences for ChIP PCR are submitted as Supplementary Information.
Illumina methylation array
Genomic DNA was extracted from cells using Qiagen DNeasy kit (Qiagen, Duesseldorf, Germany). Purified DNA was bisulfite treated with EpiTect Bisulfite kit (Qiagen). DNA methylation levels of bisulfite converted DNAs were measured using Illumina Infinium or GoldenGate methylation assays (Illumina, San Diego, CA, USA) according to the manufacturer's protocol. Methylation and differential methylation analyses were performed in BeadStudio (Illumina). In group comparisons, differentially methylated targets were determined based on abs (DiffScore)425, as described earlier (Killian et al., 2009 ).
Illumina gene expression array
A total of 200 ng of total RNA was amplified and cRNA was labeled with biotin using Illumina TotalPrep RNA amplification kit (Ambion, Austin, TX, USA); 750 ng of biotin labeled cRNA was hybridized to Sentrix BeadChip Array for Gene Expression HumanRef-8 V2 (Illumina) and incubated at 58 1C for 16-20 h in an Illumina hybridization oven with rocker speed at 5. Beadchips were washed and stained according to Illumina's protocol. Arrays were scanned by Illumina chip scanner, and images analyzed by Bead Studio (Illumina). Data were exported and processed using Genespring GX 7.31 (Agilent, Santa Clara, CA, USA). Differentially regulated genes between TSC-treated and control cells were identified by statistical significance Po0.05 and fold change 41.5. Significantly regulated genes were subjected to further analysis using Ingenuity Pathway software (Ingenuity, Redwood City, CA, USA).
Soft-agar assays
Submitted as Supplementary Information.
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